Status:
RECRUITING
Diabetes Registry Graz for Biomarker Research
Lead Sponsor:
Medical University of Graz
Conditions:
Type1diabetes
Type 2 Diabetes
Eligibility:
All Genders
18-99 years
Brief Summary
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect ...
Detailed Description
Obesity and diabetes represent probably the most challenging threat to public health in the 21st century. Despite well-controlled established cardiovascular risk factors, the residual risk in subject...
Eligibility Criteria
Inclusion
- 18 - 99 years
- Informed consent has to be given in written form
- At least one of the following diseases:
- Type 1 diabetes
- Type 2 diabetes
- Type 3 diabetes
- Maturity onset diabetes of young (MODY)
- Late onset diabetes of the adult (LADA)
- Adipositas (BMI \> 30kg/m2)
- Lipid metabolism disorder
Exclusion
- No written informed consent
- No willingness to participate in this registry
Key Trial Info
Start Date :
October 21 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2035
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05324488
Start Date
October 21 2015
End Date
February 1 2035
Last Update
July 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria, 8010